Study of AXT-1003 in Subjects With Advanced Malignant Tumors.
Study of AXT-1003 in Subjects With Advanced Malignant Tumors.
Recruiting · NCT06484985 · Registry updated 2026-01-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of AXT-1003 in Subjects With Advanced Malignant Tumors. | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma | Recruiting | Phase 1 | 2026-01-28 | NCT06484985 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Axter Therapeutics (Beijing) Co., Ltd | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 85 |
| Fudan University Shanghai Cancer Center | Shanghai | China | 128 |
| Fujian Cancer Hospital | Fuzhou | China | 37 |
| Hunan Cancer Hosptial | Changsha | China | 1 |
| Sun Yat-Sen University Cancer Center | Guangzhou | China | 66 |